Pasar al contenido principal

GENERACION DE BIOMATERIALES DE TITANIO CON RIGIDEZ SUPERFICIAL MODULABLE, PROPIEDADES OSTEOINDUCTIVAS Y MITIGACION DE LA RESPUESTA FIBROTICA

PID2023-152058OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD POLITECNICA DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Stabilization of CXCL12 (SDF-1α) via silk fibroin films enhances stem cell migration/retention and functional recovery after stroke

  • Lekouaghet, Amira
  • Sánchez Díez, Marta
  • Pérez-Rigueiro, José
  • Rojo, Francisco Javier
  • Ramírez-Castillejo, Carmen
  • Ruiz-León, Yolanda
  • Panetsos, Fivos
  • Guinea, Gustavo Víctor
  • González Nieto, Daniel
19 p.-- 1 tabla .-- 5 figuras, Brain pathologies such as ischemic stroke or traumatic brain injury (TBI) are among the most impactful diseases worldwide. In ischemic stroke, we currently lack truly effective treatments capable of delaying infarct progression, limiting lesion size or stimulating endogenous brain repair mechanisms to promote neurovascular remodeling and functional recovery. Two main barriers continue to limit the clinical translation of therapeutic molecules: the highly restrictive nature of the blood-brain barrier and that many bioactive molecules exhibit low stability at the target site, with half-lives shorter than the therapeutic window. In this study, we developed tunable silk fibroin (SF) films of variable concentration, fabricated via water annealing, that effectively preserve the functional activity of the chemokine CXCL12 (SDF-1α). The 2% SF formulation provided sustained release of SDF-1α for at least 7 days, promoting the in vitro migration of mesenchymal stem cells (MSCs) and low-density bone marrow mononuclear cells (LDBM), the latter containing hematopoietic stem cells. When implanted on the cortical surface, the SDF-1α-SF films successfully stimulated the guided migration of exogenously administered MSCs and LDBM from subcortical regions into the cerebral cortex. Furthermore, co-implantation of SDF-1α-SF films with MSCs or LDBM enhanced cell retention at the cortical site, effectively minimizing off-target dispersion. In a photothrombotic model of cortical ischemia, allowing precise control of lesion location and size, SDF-1α-SF films significantly reduced lesion volume and preserved neuronal function in the somatosensory cortex, as assessed by electrophysiology. Our findings provide proof of concept for using chemokine-releasing biomaterials to actively modulate stem cell migration and retention within the brain, offering strong potential for neuroprotection and tissue remodeling in areas at risk or already affected by damage., This study was partially funded by the Ministerio de Ciencia e Innovación (grant PID2023-152058OB-I00), by the Comunidad de Madrid (Spain) (grants MINA-CM P2022-BMD-7236 and PEJ-2023-AI/SAL-Gl-2681), by a scientific grant for research projects from Mutua Madrileña (“Ayudas a la Investigación FMMA 2023”), by the Instituto de Salud Carlos III and co-funded by European Regional Development Funds (FEDER) through Project PI24-01783, and by the European Union’s EIC Pathfinder Programme, under the projects THOR (Grant Agreement No. 101099719) and ISOS (Grant Agreement No. 101130454)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Slow-wave-modulated high-frequency oscillations reveal early network abnormalities in pre-pathological 5XFAD mice

  • García-Peña, Pablo
  • Ramos, Milagros
  • López, Juan M.
  • Martínez-Murillo, Ricardo
  • Arcas, Guillermo de
  • González-Nieto, Daniel
Alzheimer's disease (AD) is characterized by progressive disruption of large-scale neural networks, leading to abnormal brain oscillatory activity, yet sensitive electrophysiological markers of the earliest disease stages remain limited. Here, we investigated intracranial EEG (iEEG) biomarkers of early network dysfunction in the 5XFAD mouse model of AD, with a particular focus on the pre-plaque stage. iEEG recordings were obtained from 5XFAD and wild-type mice at 1 month (young), 3-4 months (adult), and 10-12 months (old). Spectral power distribution, epileptiform activity, and phase-amplitude coupling (PAC) were analyzed. Young 5XFAD mice exhibited detectable amyloid-β species in cortical and hippocampal regions in the absence of amyloid plaques, neuroinflammation, or neuronal loss, indicating an early pathological stage. Despite the lack of overt histopathology, young 5XFAD mice already showed reduced low-frequency power and increased high-frequency oscillation (HFO) power. Similar spectral alterations were observed in adult animals, together with prominent epileptiform activity and seizures. Notably, we demonstrate for the first time that pathological HFO activity in 5XFAD mice is associated with altered phase-amplitude coupling (PAC) with slow oscillations, characterized by enhanced coupling between HFO amplitude and delta phase during interictal periods. In young mice, increased coupling between fast-ripple activity and theta phase was also detected, indicating that cross-frequency network dysfunction emerges before plaque deposition. In contrast, old 5XFAD mice showed no consistent differences in iEEG spectral features relative to age-matched controls. These results show that increased HFO activity and its dysregulated coupling to low-frequency rhythms represent early and sensitive electrophysiological signatures of cortical hyperexcitability and network disruption in AD, preceding overt amyloid plaque formation and neurodegeneration, and highlight the translational potential of combined HFO power and PAC metrics as biomarkers for early-stage AD., This study was funded by the Ministerio de Ciencia e Innovación (Spain) (grant PID2023-152058OB-I00), by Comunidad de Madrid (Spain) (grant MINA-CM P2022-BMD-7236 and PEJ-2023-AI/SAL-Gl-2681), and by the European Union's EIC-Pathfinder Programme, under the project THOR (Grant Agreement number 101099719). P.G-P.'s contract is part of the PTA2023-023245-I grant, funded by the Ministerio de Ciencia e Innovación, Agencia Española de Investigación MICIU/AEI/10.13039/501100011033 and by the European Social Fund Plus (ESF+)., Peer reviewed